David E. Lazar

CIK 1932843 · Chief Executive Officer · last filed 2026-05-01

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.21M

Companies

13

Total Filings

28

Lifetime Open-Market Net

-$5.43M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ATER Director 0 $0.39 $0 $0 1 2026-05-01
QUCY Chief Executive Officer 0 $1.09 $0 $0 1 2026-04-28
SOWG Chief Executive Officer 382,667 $3.17 $1.21M $0 2 2026-04-02
INDP Director $1.73 $0 1 2026-03-24
Quantum Cyber N.V. (MYNZ) Delisted Director 0 $0.84 $0 $0 1 2026-03-03
Stablecoin Development Corp (NBY) Delisted 10%+ Owner 6,388,000 $1.95 $12.46M $0 2 2026-01-29
KALA Chief Executive Officer 0 $0.66 $0 $0 2 2025-12-22
Bio Green Med Solution, Inc. (CYCCP) Delisted Interim CEO 155,838 $5.05 $787.0K -$5.59M 3 2025-08-04
YHC President 29 $1.39 $40 $0 1 2025-04-07
FiEE, Inc. (MINM) Delisted Director 2,681,980 $3.61 $9.68M $50.0K 5 2025-03-10
LQR House Inc. (LQR) Delisted President 0 $1.15 $0 $0 1 2024-11-25
OPGEN INC (OPGN) Delisted Chief Executive Officer 10,000 $24.75 $247.5K $0 6 2024-08-01
TITAN PHARMACEUTICALS INC (TTNP) Delisted Chief Executive Officer 22,953 $4.61 $105.8K $112.6K 2 2023-07-31

Recent Filings · Page 3 of 3

28 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-07-31 OPGEN INC (OPGN) Delisted Grant (A) $0 EDGAR
2024-04-25 OPGEN INC (OPGN) Delisted Buy (P) $0 EDGAR
2024-04-12 OPGEN INC (OPGN) Delisted Grant (A) +100,000 $0 EDGAR
2024-04-08 OPGEN INC (OPGN) Delisted Buy (P) $0 EDGAR
2024-01-31 FiEE, Inc. (MINM) Delisted Buy (P) $0 EDGAR
2024-01-24 FiEE, Inc. (MINM) Delisted Grant (A) +25,000 $0 EDGAR
2023-07-31 TITAN PHARMACEUTICALS INC (TTNP) Delisted Grant (A) +100,000 $0 EDGAR
2023-01-26 TITAN PHARMACEUTICALS INC (TTNP) Delisted Buy (P) +115,000 $112.6K EDGAR
Showing 2128 of 28
Page 3 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.